BioCentury
ARTICLE | Clinical News

Sofosbuvir/velpatasvir/voxilaprevir: Phase III data

October 31, 2016 7:00 AM UTC

Top-line data from the open-label, international Phase III POLARIS-3 trial in 219 patients with chronic HCV genotype 3 infection and compensated cirrhosis who were not previously treated with a direct...